Orthofix Medical Inc. (NASDAQ:OFIX), a global medical technology company renowned for its innovative orthopedic solutions, recently unveiled its third-quarter 2025 financial results. The company reported an earnings per share (EPS) of -$0.57, falling short of the anticipated EPS of $0.12. Despite this setback, Orthofix's revenue reached approximately $205.6 million, exceeding the forecasted $200 million. Orthofix Medical Inc. (NASDAQ:OFIX) reported a Q3 2025 EPS of -$0.57, missing the estimated EPS of $0.12 ...